Mike Gresser, Ph.D. is Chief Scientific Officer for ImmuneGene. From 2000-2006, Dr. Gresser served as Vice President, Research for Inflammation at Amgen, Inc. Prior to Amgen, he was at the Merck Frosst Center for Therapeutic Research where he rose to be Executive Director of Biochemistry and Molecular Biology. He received his Ph.D in Biochemistry from Brandeis University and did postdoctoral studies at UCLA. Before joining Merck Frosst in 1988 he was Pr ofessor of Chemistry at Simon Frazer University in Burnaby, British Columbia.